BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17071481)

  • 1. Deciphering leukemic B-cell chronic lymphoproliferative disorders.
    Ugo V; Leporrier N; Salaun V; Letestu R; Radford-Weiss I; Ramond S; Nataf J; Guesnu M; Picard F; Brouzes C; Perrot JY; Valensi F; Levy V; Ajchenbaum-Cymbalista F; Troussard X
    Leuk Lymphoma; 2006 Oct; 47(10):2088-95. PubMed ID: 17071481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.
    Dronca RS; Jevremovic D; Hanson CA; Rabe KG; Shanafelt TD; Morice WG; Call TG; Kay NE; Collins CS; Schwager SM; Slager SL; Zent CS
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S35-41. PubMed ID: 20568273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders.
    Letestu R; Ugo V; Valensi F; Radford-Weiss I; Nataf J; Lévy V; Gribben JG; Troussard X; Ajchenbaum-Cymbalista F
    Leukemia; 2004 May; 18(5):953-61. PubMed ID: 15029207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP; Variakojis D; Peterson LC
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
    Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
    Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.
    Chen D; Law ME; Theis JD; Gamez JD; Caron LB; Vrana JA; Dogan A
    Am J Surg Pathol; 2009 May; 33(5):720-9. PubMed ID: 19145199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicentric chromosome 3 associated with binucleated lymphocytes in atypical B-cell chronic lymphoproliferative disorder.
    Samson T; Mossafa H; Lusina D; Fagot T; Souleau B; de Revel T; Troussard X; Nedellec G
    Leuk Lymphoma; 2002 Sep; 43(9):1749-54. PubMed ID: 12685827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression.
    Deneys V; Michaux L; Leveugle P; Mazzon AM; Gillis E; Ferrant A; Scheiff JM; De Bruyère M
    Leukemia; 2001 Sep; 15(9):1458-65. PubMed ID: 11516108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias.
    Goldaniga M; Ferrario A; Cortelazzo S; Guffanti A; Pavone E; Ambrosetti A; Marcheselli L; Rossi F; Luminari S; Rossi A; Cro L; Federico M; Lambertenghi Deliliers G; Baldini L
    Am J Hematol; 2008 May; 83(5):349-54. PubMed ID: 18186522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic B-cell lymphoproliferative disorders: how many diseases?
    Zent CS
    Leuk Lymphoma; 2006 Oct; 47(10):2006-7. PubMed ID: 17071467
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E; Carrara P; Morilla R; Matutes E
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
    J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
    Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
    Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
    Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
    Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.
    Baseggio L; Geay MO; Gazzo S; Berger F; Traverse-Glehen A; Ffrench M; Hayette S; Callet-Bauchu E; Verney A; Morel D; Jallades L; Magaud JP; Salles G; Felman P
    Br J Haematol; 2012 Aug; 158(4):489-98. PubMed ID: 22686190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.